Leonardo DO Carmo Nakamura¹, Letycia Sette Vieira¹, Gabriele Monteiro² and Zamir Calamita³*

¹Graduation - Marília Medical School (FAMEMA) - Marília - São Paulo - Brazil
²Biomedical - Blood Center - FAMEMA - Marília - São Paulo - Brazil
³Medical Immunologist - PhD - Department of Immunology and Allergy - FAMEMA - Marília, São Paulo, Brazil

*Corresponding Author: Zamir Calamita, Medical Immunologist - PhD - Department of Immunology and Allergy - FAMEMA - Marília, São Paulo, Brazil.

Received: July 18, 2023; Published: September 14, 2023

Abstract

This is a case-control study in which elderly patients were compared regarding the presence or absence of neoplasms, dependent or not on ANA positivity. The control was composed of those with negative ANA and the group of cases was composed with those with positive ANA in low to moderate titers. The information was collected from a database of the immunology sector of the Blood Center of the Marília Medical School, state of São Paulo, Brazil. We evaluated 31 ANA positive patients (cases) and 36 ANA negative (controls). An OR = 1.93 (95% CI= 0.66 – 5.65) was found indicating a favorable trend for the association between ANA positivity and the presence of neoplasms, but without statistical significance. We believe more research is needed with larger samples in the study of this subject.

 Keywords: Antinucleus Factor; Coarse Speckled (CS); Drugs

References

1. Dellavance A and Andrade LEC. “Como interpretar e valorizar adequadamente o teste de anticorpos antinúcleo”. Jornal Brasileiro de Patologia e Medicina Laboratorial 43 (2007): 157-168.
2. Cezar JPL., et al. “O Teste do Fator Antinúcleo (FAN) na prática clínica: quando solicitar e como interpretar”. Acta Médica (Porto Alegre) 34 (2013): 6.
3. Health BCMo. “Antinuclear Antibody (ANA) Testing Protocol Internet” (2013).
4. Torres P. Entenda o que é o exame: FAN – Fator antinuclear: Associação Brasileira Superando Lupus; (2018).
5. Dellavance A., et al. “3º Consenso Brasileiro para pesquisa de autoanticorpos em células HEp-2 (FAN): recomendações para padronização do ensaio de pesquisa de autoanticorpos em células HEp-2, controle de qualidade e associações clínicas”. Revista Brasileira de Reumatologia 49 (2009): 89-98.
6. Sun Q., et al. “Presence of serum antinuclear antibodies correlating unfavorable overall survival in patients with chronic lymphocytic leukemia”. Chinese Medical Journal5 (2019): 525-533.
7. Skare TL., et al. “Antinuclear antibodies in patients with cervical lesions and invasive cervical cancer”. Immunology Letter 208 (2019): 8-10.
8. Paradella R. Número de idosos cresce 18% em 5 anos e ultrapassa 30 milhões em 2017 Agência de notícias IBGE (2018).
9. Fêde ABdS., et al. “A importância das neoplasias na população idosa brasileira de 2000 a 2005”. Einstein (2009): 6.

Citation

Citation: Zamir Calamita., et al. “Possible Correlation Between ANA Positivity and Neoplasms in the Elderly: Preliminary Results”.Acta Scientific Medical Sciences 7.10 (2023): 34-37.

Copyright

Copyright: © 2023 Zamir Calamita., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.